Olli Arjamaa
- Molecular Biology
- Cardiology and Cardiovascular Medicine top 5%
- Ophthalmology top 2%
- Pulmonary and Respiratory Medicine
- Physiology
- Co-authors
- Mikko NikinmaaOlli VuolteenahoNicholas LingKai KaarnirantaHeikki RuskoahoJuhani LeppäluotoAntero SalminenOlli Vakkuri
- Topics
- Heart Failure Treatment and Management (11 papers)Retinal Diseases and Treatments (6 papers)Cardiovascular Function and Risk Factors (6 papers)
- Journals
- Circulation ResearchThe Journal of PhysiologyBiochemical and Biophysical Research Communications
- Partner nations
- FinlandHungaryUnited States
In The Last Decade
Olli Arjamaa
58 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 116
- Molecular Biology 413
- Cardiology and Cardiovascular Medicine 413
- Ophthalmology 314
- Pulmonary and Respiratory Medicine 157
- Physiology 157
Countries citing papers authored by Olli Arjamaa
This map shows the geographic impact of Olli Arjamaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olli Arjamaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olli Arjamaa more than expected).
Fields of papers citing papers by Olli Arjamaa
This network shows the impact of papers produced by Olli Arjamaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olli Arjamaa. The network helps show where Olli Arjamaa may publish in the future.
Co-authorship network of co-authors of Olli Arjamaa
This figure shows the co-authorship network connecting the top 25 collaborators of Olli Arjamaa. A scholar is included among the top collaborators of Olli Arjamaa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olli Arjamaa. Olli Arjamaa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 22 | |
| 5 | 32 | |
| 6 | 19 | |
| 7 | 13 | |
| 8 | 228 | |
| 9 | 15 | |
| 10 | 7 | |
| 11 | 5 | |
| 12 | 34 | |
| 13 | 7 | |
| 14 | 6 | |
| 15 | 8 | |
| 16 | 12 | |
| 17 | 2 | |
| 18 | 7 | |
| 19 | 12 | |
| 20 | 3 |
About Olli Arjamaa
Olli Arjamaa is a scholar working on Cardiology and Cardiovascular Medicine, Ophthalmology and Nephrology, having authored 59 papers that have together received 1.3k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (11 papers), Retinal Diseases and Treatments (6 papers) and Cardiovascular Function and Risk Factors (6 papers). The work is most often cited by research in Ophthalmology (314 citations), Cardiology and Cardiovascular Medicine (413 citations) and Aquatic Science (52 citations). Olli Arjamaa has collaborated with scholars based in Finland, Hungary and United States. Frequent co-authors include Mikko Nikinmaa, Olli Vuolteenaho, Nicholas Ling, Kai Kaarniranta, Heikki Ruskoaho, Juhani Leppäluoto, Antero Salminen, Olli Vakkuri, Mika Laine and A. Talo. Their work appears in journals such as Circulation Research, The Journal of Physiology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.